Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingrui Li

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Iscience|March 14, 2025
TAF7 directly targets SAA1 to enhance triple-negative breast cancer metastasis via phosphorylating E-cadherin and N-cadherinWanjun Zhang, Jun Wang, Hanning Li, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2021
CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid CancerHanning Li, Xiang Zhou, Ge Wang, et al.
BMC Cancer|September 13, 2024
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancerQingyuan Zhang, Zhonghua Wang, Wei Yao, et al.
Eclinicalmedicine|September 29, 2020
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020Jianbin Li, Haibo Wang, Cuizhi Geng, et al.
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Iscience|March 14, 2025
TAF7 directly targets SAA1 to enhance triple-negative breast cancer metastasis via phosphorylating E-cadherin and N-cadherinWanjun Zhang, Jun Wang, Hanning Li, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2021
CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid CancerHanning Li, Xiang Zhou, Ge Wang, et al.
BMC Cancer|September 13, 2024
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancerQingyuan Zhang, Zhonghua Wang, Wei Yao, et al.
Eclinicalmedicine|September 29, 2020
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020Jianbin Li, Haibo Wang, Cuizhi Geng, et al.
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Pageof 11